CVRX CVRx, Inc. - Common Stock

NASDAQ · Health Care · 在 SEC EDGAR 上查看 ↗
$2.73
价格 · 八月 19, 2026
截至...的财报数据 八月 6, 2026

关于 CVRx, Inc. - Common Stock 公司概况(来自维基百科)

CVRX 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围

价格
$2.73
市值
$72M
P/E (TTM)
-1.3
每股收益 (TTM)
$-2.04
营收 (TTM)
$57M
股息收益率
ROE
-109.6%
负债/权益
1.3
52周区间
$2 – $11

CVRX 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图

10年表现 收入、净利润、利润率和每股收益趋势

营收与净利润 $57M
6-point trend, +835.9%
2020-12-31 2025-12-31
EPS $-2.04
5-point trend, +51.0%
2021-12-31 2025-12-31
自由现金流 $-41M
5-point trend, -40.9%
2021-12-31 2025-12-31
利润率 -94.1%
5-point trend, +18.4%
2021-12-31 2025-12-31

估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜?

指标
5年趋势
CVRX
同行中位数
P/E (TTM)
5-point trend, -18.4%
-1.3
27.5
P/S (TTM) (市销率 (TTM))
5-point trend, -82.8%
1.3
2.8
P/B (市净率)
5-point trend, +177.9%
1.8
4.5
EV / EBITDA (企业价值 / EBITDA)
5-point trend, +24.3%
-0.9
Price / FCF (股价/自由现金流)
5-point trend, +46.9%
-1.8

盈利能力 毛利率、营业利润率和净利率;股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)

指标
5年趋势
CVRX
同行中位数
Gross Margin (毛利率)
5-point trend, +18.4%
85.3%
59.5%
Operating Margin (营业利润率)
5-point trend, +54.6%
-90.5%
Net Profit Margin (净利润率)
5-point trend, +71.5%
-94.1%
-21.3%
ROA
5-point trend, -12.9%
-44.8%
-19.0%
ROE
5-point trend, -284.0%
-109.6%
-25.2%
ROIC
5-point trend, -223.6%
-57.7%

财务健康 债务、流动性、偿付能力 — 资产负债表强度

指标
5年趋势
CVRX
同行中位数
Debt / Equity (负债/股东权益比率)
5-point trend, +1.26
1.3
Current Ratio (流动比率)
5-point trend, -70.2%
7.6
2.9
Quick Ratio (速动比率)
5-point trend, -73.5%
6.5

成长 营收、每股收益 (EPS) 和净利润增长:同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)

指标
5年趋势
CVRX
同行中位数
Revenue YoY (营收同比增长)
5-point trend, +334.6%
10.4%
Revenue CAGR 3Y (营收3年复合年增长率)
5-point trend, +334.6%
36.1%
Revenue CAGR 5Y (营收5年复合年增长率)
5-point trend, +334.6%
56.4%

每股指标 每股收益 (EPS)、每股净资产、每股现金流、每股股息

指标
5年趋势
CVRX
同行中位数
EPS (Diluted) (EPS (稀释))
5-point trend, +51.0%
$-2.04

资本效率 资产周转率、库存周转率、应收账款周转率

指标
5年趋势
CVRX
同行中位数

CVRX 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间

买入 13 位分析师
  • 强烈买入 3 23.1%
  • 买入 8 61.5%
  • 持有 1 7.7%
  • 卖出 1 7.7%
  • 强烈卖出 0 0.0%

12个月价格目标

6 位分析师 · 2026-08-15
中位数目标 $4.50 +64.6%
平均目标 $5.92 +116.4%

收益历史 每股收益实际值 vs 预估值,惊喜%,达标率,下次财报日期

平均惊喜
0.01%
期间 EPS Actual EPS 预期 惊喜
2026年6月30日 $-0.53 $-0.53 0.00%
2026年3月31日 $-0.50 $-0.51 0.01%
2025年12月31日 $-0.46 $-0.45 -0.01%
2025年9月30日 $-0.49 $-0.51 0.02%
2025年6月30日 $-0.57 $-0.53 -0.04%
2025年3月31日 $-0.53 $-0.58 0.05%

同行比较(GICS 子行业) 关键指标与行业同行对比

股票代码 市值 P/E 营收同比增长 净利润率 ROE 毛利率
CVRX $187M -3.5 10.4% -94.1% -109.6% 85.3%
OM $67M -0.7 5.1% -68.3% -58.0% 39.1%
VANI $94M -2.9 -257.8%
ODYS $54M -3.1 -23.9% -565.0% -58.7% 28.9%
DXR
COCH
MDAI

完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表

损益表 17
CVRX 的年度损益表数据
指标 趋势 202520242023202220212020
Revenue 6-point trend, +835.9% $57M $51M $39M $22M $13M $6M
Cost of Revenue 6-point trend, +477.2% $8M $8M $6M $5M $4M $1M
Gross Profit 6-point trend, +947.9% $48M $43M $33M $17M $9M $5M
R&D Expense 6-point trend, +73.7% $11M $11M $12M $10M $8M $6M
SG&A Expense 6-point trend, +810.5% $88M $91M $65M $50M $28M $10M
Operating Expenses 6-point trend, +517.6% $100M $102M $76M $60M $35M $16M
Operating Income 6-point trend, -345.2% $-51M $-59M $-43M $-43M $-26M $-12M
Interest Expense 4-point trend, -27.2% · · $2M $165.0K $2M $2M
Other Non-op 6-point trend, +9520.0% $4M $4M $4M $1M $-15M $-40.0K
Pretax Income 6-point trend, -280.2% $-53M $-60M $-41M $-41M $-43M $-14M
Income Tax 6-point trend, -121.2% $-18.0K $55.0K $147.0K $109.0K $91.0K $85.0K
Net Income 6-point trend, -277.8% $-53M $-60M $-41M $-41M $-43M $-14M
EPS (Basic) 5-point trend, +51.0% $-2.04 $-2.65 $-1.99 $-2.02 $-4.16 ·
EPS (Diluted) 5-point trend, +51.0% $-2.04 $-2.65 $-1.99 $-2.02 $-4.16 ·
Shares (Basic) 5-point trend, +151.8% 26,084,709 22,596,229 20,754,375 20,532,838 10,360,054 ·
Shares (Diluted) 5-point trend, +151.8% 26,084,709 22,596,229 20,754,375 20,532,838 10,360,054 ·
EBITDA 5-point trend, -97.4% $-51M $-59M $-43M $-43M $-26M ·
资产负债表 24
CVRX 的年度资产负债表数据
指标 趋势 202520242023202220212020
Cash & Equivalents 6-point trend, +28.1% $76M $106M $91M $106M $142M $59M
Receivables 6-point trend, +732.6% $11M $9M $8M $6M $3M $1M
Inventory 6-point trend, +265.1% $12M $12M $11M $7M $4M $3M
Prepaid Expense 6-point trend, +407.3% $3M $3M $3M $4M $3M $605.0K
Current Assets 6-point trend, +58.0% $102M $130M $112M $123M $151M $64M
PP&E (Net) 6-point trend, +447.1% $2M $3M $2M $2M $1M $410.0K
PP&E (Gross) 6-point trend, +202.9% $6M $6M $5M $4M $3M $2M
Accum. Depreciation 6-point trend, +144.0% $4M $3M $3M $2M $2M $2M
Other Non-current Assets 6-point trend, +0.0% $26.0K $27.0K $27.0K $27.0K $26.0K $26.0K
Total Assets 6-point trend, +61.8% $105M $133M $115M $125M $153M $65M
Accounts Payable 6-point trend, +693.6% $4M $3M $2M $2M $510.0K $483.0K
Accrued Liabilities 6-point trend, +164.7% $9M $8M $6M $6M $5M $4M
Current Liabilities 6-point trend, +66.9% $13M $11M $8M $8M $6M $8M
Capital Leases 5-point trend, +638000.00 $638.0K $877.0K $1M $117.0K $0 ·
Other Non-current Liabilities 6-point trend, +157.5% $2M $1M $1M $805.0K $681.0K $777.0K
Total Liabilities 6-point trend, +133.6% $65M $62M $39M $16M $7M $28M
Long-term Debt · · · · · $19M
Total Debt 5-point trend, +49514000.00 $50M $49M $29M $7M $0 ·
Common Stock 6-point trend, +6475.0% $263.0K $253.0K $209.0K $207.0K $204.0K $4.0K
Retained Earnings 6-point trend, -68.0% $-591M $-537M $-477M $-436M $-395M $-352M
AOCI 6-point trend, -6.8% $-203.0K $-206.0K $-207.0K $-207.0K $-198.0K $-190.0K
Stockholders' Equity 6-point trend, +113.4% $39M $71M $76M $109M $146M $-293M
Liabilities + Equity 6-point trend, +61.8% $105M $133M $115M $125M $153M $65M
Shares Outstanding 6-point trend, +7200.4% 26,311,607 25,324,684 20,879,199 20,663,736 20,399,337 360,412
现金流 11
CVRX 的年度现金流数据
指标 趋势 202520242023202220212020
Stock-based Comp 6-point trend, +8272.7% $11M $19M $6M $4M $2M $132.0K
Operating Cash Flow 6-point trend, -149.6% $-40M $-39M $-39M $-43M $-28M $-16M
CapEx 6-point trend, +86.5% $580.0K $1M $591.0K $685.0K $1M $311.0K
Investing Cash Flow 6-point trend, -86.5% $-580.0K $-1M $-591.0K $-685.0K $-1M $-311.0K
Net Debt Issued 2-point trend, +100.0% · · · $0 $-21M ·
Stock Issued 6-point trend, +8974000.00 $9M $33M $0 $0 $133M $0
Net Stock Activity 4-point trend, -93.3% $9M $33M · $0 $133M ·
Financing Cash Flow 6-point trend, -78.9% $11M $56M $24M $7M $112M $50M
Net Change in Cash 6-point trend, -190.6% $-30M $15M $-16M $-36M $83M $33M
Free Cash Flow 5-point trend, -40.9% $-41M $-41M $-40M $-43M $-29M ·
Levered FCF 3-point trend, -33.0% · · $-41M $-44M $-31M ·
盈利能力 8
CVRX 的年度盈利能力数据
指标 趋势 202520242023202220212020
Gross Margin 5-point trend, +18.4% 85.3% 83.8% 84.1% 77.8% 72.1% ·
Operating Margin 5-point trend, +54.6% -90.5% -116.0% -109.7% -189.3% -199.2% ·
Net Margin 5-point trend, +71.5% -94.1% -116.9% -104.8% -184.4% -330.4% ·
Pretax Margin 5-point trend, +71.5% -94.1% -116.8% -104.5% -183.9% -329.8% ·
EBITDA Margin 5-point trend, +54.6% -90.5% -116.0% -109.7% -189.3% -199.2% ·
ROA 5-point trend, -12.9% -44.8% -48.2% -34.3% -29.9% -39.6% ·
ROE 5-point trend, -284.0% -109.6% -88.0% -51.9% -36.4% -28.5% ·
ROIC 5-point trend, -223.6% -57.7% -49.5% -41.1% -36.8% -17.8% ·
流动性与偿付能力 5
CVRX 的年度流动性与偿付能力数据
指标 趋势 202520242023202220212020
Current Ratio 5-point trend, -70.2% 7.6 12.1 14.3 15.2 25.6 ·
Quick Ratio 5-point trend, -73.5% 6.5 10.7 12.5 13.8 24.5 ·
Debt / Equity 5-point trend, +1.26 1.3 0.7 0.4 0.1 0.0 ·
LT Debt / Equity 5-point trend, +1.26 1.3 0.7 0.4 0.1 0.0 ·
Interest Coverage 3-point trend, -104.7% · · -24.0 -257.7 -11.7 ·
效率 3
CVRX 的年度效率数据
指标 趋势 202520242023202220212020
Asset Turnover 5-point trend, +296.3% 0.5 0.4 0.3 0.2 0.1 ·
Inventory Turnover 5-point trend, -32.2% 0.7 0.7 0.7 0.9 1.0 ·
Receivables Turnover 5-point trend, -16.3% 5.7 6.1 6.0 5.6 6.8 ·
每股 5
CVRX 的年度每股数据
指标 趋势 202520242023202220212020
Book Value / Share 5-point trend, -79.1% $1.49 $2.81 $3.64 $5.29 $7.16 ·
Revenue / Share 4-point trend, +98.5% $2.17 $2.27 $1.89 $1.09 · ·
Cash Flow / Share 4-point trend, +25.9% $-1.54 $-1.73 $-1.88 $-2.08 · ·
Cash / Share 5-point trend, -58.7% $2.88 $4.18 $4.34 $5.15 $6.96 ·
EPS (TTM) 5-point trend, +51.0% $-2.04 $-2.65 $-1.99 $-2.02 $-4.16 ·
增长率 3
CVRX 的年度增长率数据
指标 趋势 202520242023202220212020
Revenue YoY 5-point trend, -90.9% 10.4% 30.5% 74.9% 72.4% 115.4% ·
Revenue CAGR 3Y 3-point trend, -58.3% 36.1% 57.9% 86.6% · · ·
Revenue CAGR 5Y 56.4% · · · · ·
估值 (TTM) 14
CVRX 的年度估值 (TTM)数据
指标 趋势 202520242023202220212020
Revenue TTM 5-point trend, +334.6% $57M $51M $39M $22M $13M ·
Net Income TTM 5-point trend, -23.7% $-53M $-60M $-41M $-41M $-43M ·
Market Cap 5-point trend, -25.1% $187M $321M $656M $379M $249M ·
Enterprise Value 5-point trend, +49.5% $161M $264M $595M $279M $107M ·
P/E 5-point trend, -18.4% -3.5 -4.8 -15.8 -9.1 -2.9 ·
P/S 5-point trend, -82.8% 3.3 6.3 16.7 16.9 19.1 ·
P/B 5-point trend, +177.9% 4.8 4.5 8.6 3.5 1.7 ·
P / Tangible Book 5-point trend, +177.9% 4.8 4.5 8.6 3.5 1.7 ·
P / Cash Flow 5-point trend, +48.3% -4.7 -8.2 -16.8 -8.9 -9.0 ·
P / FCF 5-point trend, +46.9% -4.6 -7.9 -16.6 -8.7 -8.6 ·
EV / EBITDA 5-point trend, +24.3% -3.1 -4.4 -13.8 -6.6 -4.1 ·
EV / FCF 5-point trend, -6.1% -3.9 -6.5 -15.0 -6.4 -3.7 ·
EV / Revenue 5-point trend, -65.6% 2.8 5.2 15.1 12.4 8.2 ·
Earnings Yield 5-point trend, +15.5% -28.7% -20.9% -6.3% -11.0% -34.0% ·

财务报表 损益表、资产负债表、现金流量表 — 年度,近5年

损益表
2025-12-312024-12-312023-12-312022-12-312021-12-31
收入 $57M$51M$39M$22M$13M
毛利率 % 85.3%83.8%84.1%77.8%72.1%
营业利润率 % -90.5%-116.0%-109.7%-189.3%-199.2%
净收入 $-53M$-60M$-41M$-41M$-43M
稀释后每股收益 (EPS) $-2.04$-2.65$-1.99$-2.02$-4.16
资产负债表
2025-12-312024-12-312023-12-312022-12-312021-12-31
负债/股东权益比率 1.30.70.40.10.0
流动比率 7.612.114.315.225.6
速动比率 6.510.712.513.824.5
现金流
2025-12-312024-12-312023-12-312022-12-312021-12-31
自由现金流 $-41M$-41M$-40M$-43M$-29M

我的指标 您的个人关注列表 — 来自完整基本面的选定行

📊

选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。

您的选择已保存,并会跟随您浏览所有股票。

机构持有人 (13F) 100 家申报者 · $63.2M 总计 · 截至 2026年6月30日

在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸;单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存,而非方向性判断。

机构活动 — Q2 2026 与上一季度对比
新仓位 已退出持仓 增加 减少 净股数变动
13 (-11 与上一季度对比) 17 (+4 与上一季度对比) 28 (-1 与上一季度对比) 29 (+8 与上一季度对比) +2K

与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天,外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过,优先显示最近一个已完整报告的季度对。

机构 价值 股份 % 已追踪的13F 类型
JOHNSON & JOHNSON $20687786 4024861 32.73% 股份
NEA Management Company, LLC $10045822 1954440 15.89% 股份
GSK plc $5178977 1007583 8.19% 股份
VANGUARD CAPITAL MANAGEMENT LLC $4680361 910576 7.41% 股份
SILVERCREST ASSET MANAGEMENT GROUP LLC $4513480 878109 7.14% 股份
GEODE CAPITAL MANAGEMENT, LLC $1942206 377698 3.07% 股份
PFM Health Sciences, LP $1899600 369572 3.01% 股份
STATE STREET CORP $1883049 366352 2.98% 股份
Nuveen Asset Management, LLC $1471114 116110 2.33% 股份
RENAISSANCE TECHNOLOGIES LLC $1182200 230000 1.87% 股份
TUDOR INVESTMENT CORP ET AL $1057216 205684 1.67% 股份
Kestra Advisory Services, LLC $680536 132400 1.08% 股份
TWO SIGMA INVESTMENTS, LP $680526 132398 1.08% 股份
VANGUARD FIDUCIARY TRUST CO $662829 128955 1.05% 股份
VANGUARD PORTFOLIO MANAGEMENT LLC $544403 105915 0.86% 股份
DIMENSIONAL FUND ADVISORS LP $543704 105779 0.86% 股份
Cresset Asset Management, LLC $533784 103849 0.84% 股份
AlphaQuest LLC $502645 70795 0.80% 股份
BNP PARIBAS FINANCIAL MARKETS $500168 97309 0.79% 股份
Quantinno Capital Management LP $423192 82333 0.67% 股份
CITADEL ADVISORS LLC $271844 52888 0.43% 股份
Nuveen, LLC $254666 49546 0.40% 股份
WOLVERINE TRADING, LLC $228312 29346 0.36% 股份
ALLIANCEBERNSTEIN L.P. $220986 23360 0.35% 股份
BRIDGEWAY CAPITAL MANAGEMENT, LLC $210226 40900 0.33% 股份
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $181946 35398 0.29% 股份
Point72 Asset Management, L.P. $137613 26773 0.22% 股份
XTX Topco Ltd $112181 21825 0.18% 股份
Jain Global LLC $109482 21300 0.17% 股份
Mitsubishi UFJ Asset Management Co., Ltd. $106532 20726 0.17% 股份
RBF Capital, LLC $102800 20000 0.16% 股份
BANK OF AMERICA CORP /DE/ $102085 19861 0.16% 股份
RHUMBLINE ADVISERS $96688 18812 0.15% 股份
Corton Capital Inc. $85461 10590 0.14% 股份
MILLENNIUM MANAGEMENT LLC $84476 16435 0.13% 股份
Graham Capital Management, L.P. $76884 14958 0.12% 股份
CWM, LLC $76238 8059 0.12% 股份
WELLS FARGO & COMPANY/MN $71986 14005 0.11% 股份
JPMORGAN CHASE & CO $71613 12056 0.11% 股份
JANE STREET GROUP, LLC $69390 13500 0.11% 买入期权
UBS Group AG $69118 13447 0.11% 股份
R Squared Ltd $68907 13406 0.11% 股份
Arax Advisory Partners $67689 13169 0.11% 股份
SUSQUEHANNA INTERNATIONAL GROUP, LLP $59588 11593 0.09% 股份
CITADEL ADVISORS LLC $58596 11400 0.09% 买入期权
GOLDMAN SACHS GROUP INC $55836 10863 0.09% 股份
Centiva Capital, LP $55065 10713 0.09% 股份
MERCER GLOBAL ADVISORS INC /ADV $44255 8610 0.07% 股份
Bank of New York Mellon Corp $42909 8348 0.07% 股份
VANGUARD GROUP INC $41329 5821 0.07% 股份
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. $36340 7070 0.06% 股份
WHITTIER TRUST CO $33780 6000 0.05% 股份
CITIGROUP INC $32469 6317 0.05% 股份
BlackRock, Inc. $32074 6240 0.05% 股份
Vanguard Global Advisers, LLC $29920 5821 0.05% 股份
NISA INVESTMENT ADVISORS, LLC $29031 5648 0.05% 股份
NEW YORK STATE COMMON RETIREMENT FUND $21557 4194 0.03% 股份
Police & Firemen's Retirement System of New Jersey $19378 3770 0.03% 股份
HighMark Wealth Management LLC $15420 3000 0.02% 股份
CAROLINAS WEALTH CONSULTING LLC $15127 1237 0.02% 股份
NORTHERN TRUST CORP $11282 2195 0.02% 股份
BARCLAYS PLC $10999 2140 0.02% 股份
Tower Research Capital LLC (TRC) $9648 1877 0.02% 股份
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $8221 869 0.01% 股份
Legal & General Group Plc $7134 1388 0.01% 股份
GAMMA Investing LLC $5392 1049 0.01% 股份
JNBA Financial Advisors $5140 1000 0.01% 股份
JONES FINANCIAL COMPANIES LLLP $4911 838 0.01% 股份
Ameritas Investment Partners, Inc. $4719 918 0.01% 股份
Jump Financial, LLC $2570 500 0.00% 股份
GROUP ONE TRADING LLC $2174 423 0.00% 股份
AQR CAPITAL MANAGEMENT LLC $2077 404 0.00% 股份
ROYAL BANK OF CANADA $2000 467 0.00% 股份
FMR LLC $1789 348 0.00% 股份
OSAIC HOLDINGS, INC. $1542 300 0.00% 股份
Archer Investment Corp $1285 250 0.00% 股份
THURSTON, SPRINGER, MILLER, HERD & TITAK, INC. $1156 225 0.00% 股份
DEUTSCHE BANK AG\ $1121 218 0.00% 股份
PROEQUITIES, INC. $1032 60 0.00% 股份
Russell Investments Group, Ltd. $971 189 0.00% 股份
True Wealth Design, LLC $895 174 0.00% 股份
Allworth Financial LP $736 143 0.00% 股份
ROTHSCHILD INVESTMENT LLC $493 96 0.00% 股份
Caitong International Asset Management Co., Ltd $350 68 0.00% 股份
GSA CAPITAL PARTNERS LLP $259 50358 0.00% 股份
Integrated Wealth Concepts LLC $225 44 0.00% 股份
SJS Investment Consulting Inc. $222 43 0.00% 股份
Sunbelt Securities, Inc. $208 22 0.00% 股份
Farther Finance Advisors, LLC $191 37 0.00% 股份
Sterling Capital Management LLC $185 36 0.00% 股份
Versant Capital Management, Inc $180 35 0.00% 股份
EverSource Wealth Advisors, LLC $149 29 0.00% 股份
Clearstead Advisors, LLC $125 24 0.00% 股份
IFP Advisors, Inc $93 18 0.00% 股份
SBI Securities Co., Ltd. $87 17 0.00% 股份
PHILADELPHIA TRUST CO $77 15000 0.00% 股份
MORGAN STANLEY $67 13 0.00% 股份
PRICE T ROWE ASSOCIATES INC /MD/ $62 12051 0.00% 股份
Essential Partners LLC $41 8 0.00% 股份
PNC Financial Services Group, Inc. $36 7 0.00% 股份

公司内部人士 21 位内幕人士 · 6 位高管 · 2 位董事

内部人士 角色 上次活动 持股数量 买入 12个月 卖出 12个月 净额 12个月
Nadim Yared Chief Executive Officer 2022年2月3日 M 21276 0 0 $0
Jared Oasheim Chief Financial Officer 2022年1月18日 A 0 0 $0
Dean Bruhn-Ding VP of Reg. Affairs and QA 2022年2月8日 M 54648 0 0 $0
Paul Verrastro Chief Marketing Officer 2022年1月18日 A 0 0 $0
Liz Galle VP of Global Clinical Research 2022年1月18日 A 0 0 $0
John Brintnall Chief Strategy Officer and Sec 2021年12月30日 M 10450 0 0 $0
Ali Behbahani 董事 2024年6月4日 A 316 0 0 $0
Johnson & Johnson Innovation - JJDC, Inc. 10% 所有者 2023年9月15日 J 0 0 0 $0
New Enterprise Associates 10, Limited Partnership 10% 所有者 2021年7月2日 C 2026083 0 0 $0
Brent Binkowski 2026年8月13日 P 56514 1 1 $72971
Martha Shadan 2026年6月1日 A 8720 0 0 $0
Mitch C. Hill, 2026年6月1日 A 8720 0 0 $0
Mudit K. Jain 2026年6月1日 A 14370 0 0 $0
Kevin J. Ballinger 2026年6月1日 A 8720 0 0 $0
Kirk Nielsen 2026年6月1日 A 8720 0 0 $0
Joseph P Slattery 2026年6月1日 A 39365 0 0 $0
DALE MICHAEL D 2026年6月1日 A 29005 0 0 $0
Gregory Morrison 2026年3月2日 A 34000 0 0 $0
Geoffrey B Pardo 2021年7月2日 C 1829022 0 0 $0
GSK plc 2021年7月2日 C 1007583 0 0 $0
John M Nehra 2021年7月2日 P 28266 0 0 $0

来自SEC表格3/4/5申报的内部人士;净额=仅公开市场买卖

激进投资者及 5%+ 股东 3 持仓

提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权,意图影响发行人(激进股东持股、董事会活动、并购)。每一行显示该申报人持仓的最新已知状态。

申报人 已申报 持股 状态 目的 申报
New Enterprise Associates 10, Limited Partnership, New Enterprise Associates 8A, Limited Partnership, NEA Partners 10, Limited Partnership, New Enterprise Associates VIII, Limited Partnership, NEA Partners VIII, Limited Partnership, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell 2025年2月20日 7.80% 修订 SEC
Cooperatieve Gilde Healthcare IV U.A., Gilde Healthcare IV Management B.V., Gilde Healthcare Holding B.V., Manapouri B.V., Martemanshurk B.V. ×4 申报 2025年2月6日 4.90% 修订 SEC
New Enterprise Associates 8A, Limited Partnership, New Enterprise Associates 10, Limited Partnership, NEA Partners 10, Limited Partnership, New Enterprise Associates VIII, Limited Partnership, NEA Partners VIII, Limited Partnership, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell ×2 申报 2024年11月7日 初始申报 SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF持仓 由 21 只交易所交易基金持有

权重仅反映直接股权持仓(N-PORT);杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。

基金 权重 单位 截至 来源
IWC · iShares Trust 0.02% 51597 SH 2026年8月8日 每日
IWO · iShares Trust 0.01% 152223 SH 2026年8月8日 每日
RSSL · Global X Funds 0.00% 7117 NS 2026年4月30日 N-PORT
IWM · iShares Trust 0.00% 364103 SH 2026年8月8日 每日
ITWO · ProShares Trust 0.00% 758 NS 2026年5月31日 N-PORT
DFAS · Dimensional ETF Trust 0.00% 41696 NS 2026年4月30日 N-PORT
UWM · ProShares Trust 0.00% 591 NS 2026年5月31日 N-PORT
URTY · ProShares Trust 0.00% 595 NS 2026年5月31日 N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS 0.00% 577 NS 2026年5月31日 N-PORT
HDG · ProShares Trust 0.00% 15 NS 2026年5月31日 N-PORT
DCOR · Dimensional ETF Trust 0.00% 1354 NS 2026年4月30日 N-PORT
IWV · iShares Trust 0.00% 5239 SH 2026年8月8日 每日
AVSC · AMERICAN CENTURY ETF TRUST 0.00% 358 NS 2026年5月31日 N-PORT
DFAC · Dimensional ETF Trust 0.00% 5367 NS 2026年4月30日 N-PORT
VXF · VANGUARD INDEX FUNDS 0.00% 204533 SH 2026年8月8日 每日
VTI · VANGUARD INDEX FUNDS 0.00% 684121 SH 2026年8月8日 每日
VTWO · VANGUARD SCOTTSDALE FUNDS 0.00% 89003 SH 2026年8月8日 每日
VTWG · VANGUARD SCOTTSDALE FUNDS 0.00% 15722 SH 2026年8月8日 每日
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 1190 SH 2026年8月8日 每日
EBI · RBB Fund Trust 0.00% 22 NS 2026年5月31日 N-PORT
DXUV · Dimensional ETF Trust 0.00% 4 NS 2026年4月30日 N-PORT